CRISPR

CRISPR2-pkd1l1

ID

ZDB-CRISPR-240826-8

Name

CRISPR2-pkd1l1

Previous Names

None

Target

pkd1l1 (1)

Sequence

5' - ACAAGCTCTGATCTGCCAGT - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Constructs

No data available

Genomic Features

Genomic Feature	Affected Genomic Regions
hsc117	pkd1l1

Expression

Gene expression in Wild Types + CRISPR2-pkd1l1

No data available

Phenotype

Phenotype resulting from CRISPR2-pkd1l1

No data available

Phenotype of all Fish created by or utilizing CRISPR2-pkd1l1

Phenotype	Fish	Conditions	Figures
intrahepatic bile duct epithelial cell decreased amount, abnormal	pkd1l1^{hsc117/hsc117} (AB)	standard conditions	Fig. 4. from Ali et al., 2023
gall bladder determination of left/right symmetry decreased process quality, abnormal	pkd1l1^{hsc117/hsc117} (AB)	standard conditions	Fig. 2. from Ali et al., 2023
liver L-alanine:2-oxoglutarate aminotransferase activity increased process quality, abnormal	pkd1l1^{hsc117/hsc117} (AB)	standard conditions	Fig. 5. from Ali et al., 2023
intrahepatic bile duct spatial pattern, abnormal	pkd1l1^{hsc117/hsc117} (AB)	standard conditions	Fig. 4. from Ali et al., 2023
lateral plate mesoderm right side lft1 expression mislocalised, abnormal	pkd1l1^{hsc117/hsc117} (AB)	standard conditions	Fig. 2. from Ali et al., 2023
lateral plate mesoderm right side lft2 expression mislocalised, abnormal	pkd1l1^{hsc117/hsc117} (AB)	standard conditions	Fig. 2. from Ali et al., 2023
heart myl7 expression spatial pattern, abnormal	pkd1l1^{hsc117/hsc117} (AB)	standard conditions	Fig. 2. from Ali et al., 2023
intrahepatic bile duct decreased length, abnormal	pkd1l1^{hsc117/hsc117} (AB)	standard conditions	Fig. 4. from Ali et al., 2023
hepaticobiliary system process decreased process quality, abnormal	pkd1l1^{hsc117/hsc117} (AB)	standard conditions	Fig. 3. from Ali et al., 2023
liver D-glutamyltransferase activity increased process quality, abnormal	pkd1l1^{hsc117/hsc117} (AB)	standard conditions	Fig. 5. from Ali et al., 2023
liver intrahepatic bile duct decreased area, abnormal	pkd1l1^{hsc117/hsc117} (AB)	standard conditions	Fig. 4. from Ali et al., 2023
lateral plate mesoderm lft1 expression spatial pattern, abnormal	pkd1l1^{hsc117/hsc117} (AB)	standard conditions	Fig. 2. from Ali et al., 2023
lateral plate mesoderm lft2 expression spatial pattern, abnormal	pkd1l1^{hsc117/hsc117} (AB)	standard conditions	Fig. 2. from Ali et al., 2023
heart looping decreased process quality, abnormal	pkd1l1^{hsc117/hsc117} (AB)	standard conditions	Fig. 2. from Ali et al., 2023

Citations